Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation
Abbeha Talib, Social Media Manager and Content Strategist at Medify HELP, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cardiology in Review, adding:
“Excited to share that our latest work has been published in Cardiology in Review:
‘Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.’
What we explored:
In this large-scale analysis, we examined whether oral anticoagulation (OAC) can be safely discontinued after successful catheter ablation for atrial fibrillation (AF), comparing long-term outcomes of OAC discontinuation (OFF-OAC) versus continuation (ON-OAC).
Key findings: (29 studies, 153,352 participants):
- No significant difference in thromboembolic risk with OAC discontinuation (OR: 0.91; P = 0.60)
- OFF-OAC significantly reduced major bleeding risk by approximately 66 percent (OR: 0.34; P less than 0.00001)
- No significant difference in all-cause mortality (OR: 0.67; P = 0.06)
- OAC discontinuation was associated with significantly lower AF recurrence (OR: 0.57; P = 0.0003)
Subgroup insights:
- Greater bleeding reduction with OAC discontinuation was observed in:
- Warfarin users (OR: 0.13) versus warfarin/NOAC users (OR: 0.43)
- Non-Asian cohorts (OR: 0.12) versus Asian cohorts (OR: 0.45)
- Patients switched to antiplatelet therapy (OR: 0.18) versus those not switched (OR: 0.44)
Takeaway:
Discontinuing OAC after successful AF ablation significantly reduces major bleeding without increasing thromboembolic or mortality risk in appropriately selected patients.
OAC may be safely withdrawn in low-risk patients (CHA₂DS₂-VASc less than 2) with careful monitoring, while high-risk patients warrant individualized decision-making.
Grateful to my coauthors Muhammad Tahir, Muhammad Abdullah Naveed, Muhammad Hamza Khan, Muhammad Shaheer Hussain Qureshi, Susheeta Rani, Abdur Rafay Bilal, Muhammad Salik Khan, Shaheer Bin Shafiq, Ali A. Mithani, Saad Ahmed Waqas and mentors for their collaboration on this project.”
Title: Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis
Authors: Tahir Muhammad, Naveed Muhammad Abdullah, Khan Muhammad Hamza, Qureshi Shaheer, Rani Susheeta, Bilal Abdur Rafay, Talib Abbeha, Uddin Muhammad Salik, Bin Shafiq Shaheer, Mithani, Ali A., Waqas Saad Ahmed
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause